KRIEGER NANCY enters TOURMALINE BIO, INC. with 250.23K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 5/6/2021ACC: 0000899243-21-018536
Officer· Chief Medical Officer
Since May 2021
250.23K
Baseline shares
100% direct
250.23K
Direct ownership
1 position
142.53K
Derivative underlying
2 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned250.23K
Total
250.23K direct250.23K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 250.23K | Direct |
| Total | 250.23K | 250.23K direct |
Derivative Holdings2
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
109.48K
Shares owned
N/A
Exercise price
5.72
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
33.04K
Shares owned
N/A
Exercise price
3.90
Expiration
—
Exercise window
—
Total
Underlying
142.53K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock | 5.72 | — | — | 109.48K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 3.90 | — | — | 33.04K | N/A |
| Total | 142.53K | 0.00 | ||||